Posts

Doctronic acquires Summer Health to expand into pediatric care

on

Bylvay Fails Phase 3 BOLD Trial in Biliary Atresia, Another Setback for Ipsen's Albireo Portfolio

on

FDA deepens Vertex's Casgevy label to include patients as young as 2

on

Shionogi Announces Supplemental Approval in Japan for Pediatric Dosage and Administration of XOCOVA to Treat COVID-19

on

Recent Pharma News: Novo Nordisk's Oral Semaglutide for Kids, Altimmune $225M Offering, Merck-Google Cloud Partnership

on

Servier Acquires Day One Biopharmaceuticals for $2.5 Billion to Expand Rare Oncology Portfolio

on

Protara Therapeutics Receives FDA Breakthrough Therapy and Fast Track Designations for TARA-002 in Pediatric Lymphatic Malformations

on

FDA Rejects Sydnexis Myopia Drug for Kids; Chugai to Buy Renalys for $98M Upfront

on

American Academy of Pediatrics Breaks with RFK Jr., CDC on COVID Vaccines for Kids

on

FDA may not renew Pfizer’s pediatric COVID-19 shot authorization, creating uncertainty for fall child vaccinations

on

Biogen Ushers Spinraza Follow-Up (Salanersen) Into Pivotal SMA Studies

on